Carrier-mediated serotonin release induced by d-fenfluramine: Studies with human neuroblastoma cells transfected with a rat serotonin transporter

被引:13
作者
Cinquanta, M
Ratovitski, T
Crespi, D
Gobbi, M
Mennini, T
Simantov, R
机构
[1] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY
[2] WEIZMANN INST SCI,DEPT MOL GENET,IL-76100 REHOVOT,ISRAEL
关键词
serotonin transporter; serotonin release; d-fenfluramine; transfected human neuroblastoma cells;
D O I
10.1016/S0028-3908(97)00064-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The NMB human neuronal cell line, transfected with a newly prepared plasmid expressing rat serotonin transporter (NMB-rSERT), shows specific [H-3]5-HT uptake which is blocked by citalopram and fenfluramine (F) stereoisomers with IC50 values (1 nM, 0.5 mu M (dF) and 5 mu M (1F), respectively) which are similar to those found in rat brain synaptosomes. d-Fenfluramine (0.5 and 10 mu M) also stimulates tritium release from NMB-rSERT cells preloaded with [H-3-]- 5-HT. The d-fenfluramine-induced [H-3-]5-HT release is blocked by 0.3 mu M citalopram and is dependent on the density of SERT expressed per cell, but is not affected by removal of Ca++ ions from the incubation medium. Manipulation of the Nat gradient across the plasma membrane (replacing 60 mM NaCl with an equimolar concentration of KCl or choline) also induced [H-3-]5-HT release from NMB-rSERT cells, which was inhibited by 0.3 mu M citalopram. These results, together with the finding that NMB-rSERT cells preloaded with 500 nM unlabelled 5-HT take up [H-3-]d-fenfluramine, make NMB-rSERT cells a valuable tool for studying the transporter-mediated exchange release induced by amphetamine derivatives. (C) 1997 Published by Elsevier Science Ltd.
引用
收藏
页码:803 / 809
页数:7
相关论文
共 33 条
[1]   CLONING AND EXPRESSION OF A FUNCTIONAL SEROTONIN TRANSPORTER FROM RAT-BRAIN [J].
BLAKELY, RD ;
BERSON, HE ;
FREMEAU, RT ;
CARON, MG ;
PEEK, MM ;
PRINCE, HK ;
BRADLEY, CC .
NATURE, 1991, 354 (6348) :66-70
[2]  
BONANNO G, 1994, J NEUROCHEM, V63, P1163
[3]  
BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO
[4]  
2-1
[5]   ANORECTIC EFFECT AND BRAIN CONCENTRATIONS OF D-FENFLURAMINE IN THE MARMOSET - RELATIONSHIP TO THE INVIVO AND INVITRO EFFECTS ON SEROTONERGIC MECHANISMS [J].
CACCIA, S ;
ANELLI, M ;
FRACASSO, C ;
FRITTOLI, E ;
GIORCELLI, P ;
GOBBI, M ;
TADDEI, C ;
GARATTINI, S ;
MENNINI, T .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1993, 347 (03) :306-312
[6]   INVOLVEMENT OF P-TYPE CA2+ CHANNELS IN THE K+-FENFLURAMINE-INDUCED AND D-FENFLURAMINE-INDUCED [H-3] 5-HT RELEASE FROM RAT HIPPOCAMPAL SYNAPTOSOMES [J].
FRITTOLI, E ;
GOBBI, M ;
MENNINI, T .
NEUROPHARMACOLOGY, 1994, 33 (06) :833-835
[7]   NEUROCHEMICAL MECHANISM OF ACTION OF DRUGS WHICH MODIFY FEEDING VIA THE SEROTONINERGIC SYSTEM [J].
GARATTINI, S ;
MENNINI, T ;
BENDOTTI, C ;
INVERNIZZI, R ;
SAMANIN, R .
APPETITE, 1986, 7 :15-38
[8]  
GARATTINI S, 1992, INT J OBESITY, V16, pS43
[9]  
GARATTINI S, 1989, NEUROCHEMICAL PHARM, P89
[10]   EVIDENCE OF AN EXOCYTOTIC-LIKE RELEASE OF [H-3] 5-HYDROXYTRYPTAMINE INDUCED BY D-FENFLURAMINE IN RAT HIPPOCAMPAL SYNAPTOSOMES [J].
GOBBI, M ;
FRITTOLI, E ;
USLENGHI, A ;
MENNINI, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 238 (01) :9-17